{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:01:45Z","timestamp":1776866505485,"version":"3.51.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1857-y","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T07:25:35Z","timestamp":1539933935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1\/T helper type 2 imbalance: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Satoko","family":"Oka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Nohgawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"1857_CR1","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1067\/mjd.2000.103643","volume":"43(5","author":"HC Nousari","year":"2000","unstructured":"Nousari HC, Kimyai-Asadi A, Stone JH. Annular leukocytoclastic vasculitis associated with monoclonal gammopathy of unknown significance. J Am Acad Dermatol. 2000;43(5:955\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1857_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1365-2230.2003.01324.x","volume":"28","author":"IB Bayer-Garner","year":"2003","unstructured":"Bayer-Garner IB, Smoller BR. Leukocytoclastic (small vessel) vasculitis in multiple myeloma. Clin Exp Dermatol. 2003;28(5):521\u20134.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"1857_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1468-3083.2004.01069.x","volume":"18","author":"NB S\u00e1nchez","year":"2004","unstructured":"S\u00e1nchez NB, Canedo IF, Garc\u00eda-Patos PE, de Unamuno P\u00e9rez P, Benito AV, Pascual AM. Paraneoplastic vasculitis associated with multiple myeloma. J Eur Acad Dermatol Venereol. 2004;18(6):731\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1857_CR4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/1529-0131(199806)41:6<1133::AID-ART23>3.0.CO;2-S","volume":"41","author":"C Garc\u00eda-Porr\u00faa","year":"1998","unstructured":"Garc\u00eda-Porr\u00faa C, Gonz\u00e1lez-Gay MA. Cutaneous vasculitis as a paraneoplastic syndrome in adults. Arthritis Rheum. 1998;41(6):1133\u20135.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1857_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1529-8019.2010.01367.x","volume":"23","author":"G Buggiani","year":"2010","unstructured":"Buggiani G, Krysenka A, Grazzini M, Va\u0161k\u016f V, Hercogov\u00e1 J, Lotti T. Paraneoplastic vasculitis and paraneoplastic vascular syndromes. Dermatol Ther. 2010;23(6):597\u2013605.","journal-title":"Dermatol Ther"},{"issue":"2","key":"1857_CR6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V73.2.517.517","volume":"73","author":"B Klein","year":"1989","unstructured":"Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, et al. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood. 1989;73(2):517\u201326.","journal-title":"Blood"},{"issue":"23","key":"1857_CR7","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1056\/NEJM199706053362307","volume":"336","author":"R Bataille","year":"1997","unstructured":"Bataille R, Harousseau JL. Multiple myeloma. N Engl J Med. 1997;336(23):1657\u201364.","journal-title":"N Engl J Med"},{"issue":"5","key":"1857_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajcp\/103.5.583","volume":"103","author":"L Glantz","year":"1995","unstructured":"Glantz L, Rintels P, Samoszuk M, Medeiros LJ. Plasma cell myeloma associated with eosinophilia. Am J Clin Pathol. 1995;103(5):583\u20137.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"1857_CR9","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1182\/blood-2006-11-056242","volume":"111","author":"M Ostad","year":"2008","unstructured":"Ostad M, Andersson M, Gruber A, Sundblad A. Expansion of immunoglobulin autoreactive T-helper cells in multiple myeloma. Blood. 2008;111(5):2725\u201332.","journal-title":"Blood"},{"issue":"4","key":"1857_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00262-011-1123-2","volume":"61","author":"S Hong","year":"2012","unstructured":"Hong S, Qian J, Li H, Yang J, Lu Y, Zheng Y, Yi Q. CpG or IFN-\u03b1 are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma. Cancer Immunol Immunother. 2012;61(4):561\u201371.","journal-title":"Cancer Immunol Immunother"},{"key":"1857_CR11","first-page":"959","volume-title":"Pediatric Dermatology","author":"PJ Lynch","year":"1988","unstructured":"Lynch PJ. Vascular reactions. In: Schachner LA, Hansen RC, editors. Pediatric Dermatology. New York: Churchill Livingstone; 1988. p. 959\u20131014."},{"issue":"5","key":"1857_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0190-9622(98)70039-8","volume":"39","author":"T Lotti","year":"1998","unstructured":"Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous small-vessel vasculitis. J Am Acad Dermatol. 1998;39(5):667\u201387.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1857_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0190-9622(88)70264-9","volume":"19","author":"JL Jorizzo","year":"1988","unstructured":"Jorizzo JL, Solomon AR, Zanolli MD, Leshin B. Neutrophilic vascular reactions. J Am Acad Dermatol. 1988;19(6):983\u20131005.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1857_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-4362.1988.tb02353.x","volume":"27","author":"N Tosca","year":"1988","unstructured":"Tosca N, Stratigos JD. Possible pathogenetic mechanisms in allergic cutaneous vasculitis. Int J Dermatol. 1988;27(5):291\u20136.","journal-title":"Int J Dermatol"},{"key":"1857_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/978-3-662-00181-3","volume-title":"Dermatology","author":"O Braun-Falco","year":"1991","unstructured":"Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. Dermatology. Berlin: Springer-Verlag; 1991. p. 620\u20133."},{"issue":"2","key":"1857_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0049-3848(84)90215-9","volume":"35","author":"GA Zimmerman","year":"1984","unstructured":"Zimmerman GA, Hill HR. Inflammatory mediators stimulate granulocyte adherence to cultured human endothelial cells. Thromb Res. 1984;35(2):203\u201317.","journal-title":"Thromb Res"},{"issue":"12","key":"1857_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/jcp.34.12.1343","volume":"34","author":"D Lowe","year":"1981","unstructured":"Lowe D, Jorizzo J, Hutt MS. Tumour-associated eosinophilia: a review. J Clin Pathol. 1981;34(12):1343\u20138.","journal-title":"J Clin Pathol"},{"issue":"1","key":"1857_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mpo.2950050111","volume":"5","author":"A Bennett","year":"1978","unstructured":"Bennett A, Bennett L, Rosner F, Korman S. Malignant lymphoma associated with marked eosinophilia. Med Pediatr Oncol. 1978;5(1):73\u20138.","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"1857_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/asheducation-2004.1.237","volume":"2004","author":"J.-L. Harousseau","year":"2004","unstructured":"Harousseau JL, Jr Shaughnessy J, Richardson P. Multiple myeloma. Hematology Am Soc Hematol Educ Program. 2004;2004(1):237\u201356.","journal-title":"Hematology"},{"issue":"14","key":"1857_CR20","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1182\/blood-2014-05-578286","volume":"124","author":"AP Kater","year":"2014","unstructured":"Kater AP, Tonino SH, Egle A, Ramsay AG. How dose lenalidomide target the chronic lymphocytic leukemia microenvironment? Blood. 2014;124(14):2184\u20139.","journal-title":"Blood"},{"issue":"10","key":"1857_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1182\/blood-2013-07-517276","volume":"123","author":"PG Richardson","year":"2014","unstructured":"Richardson PG, Xie W, Jagannath S, Jakubowiak A, Lonial S, Raje NS, et al. A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed\/refractory myeloma. Blood. 2014;123(10):1461\u20139.","journal-title":"Blood"},{"issue":"6","key":"1857_CR22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1158\/1078-0432.CCR-10-1925","volume":"17","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Attal M, Roussel M. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival. Clin Cancer Res. 2011;17(6):1253\u201363.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1857-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1857-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1857-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:07:45Z","timestamp":1572480465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1857-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1857-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SO and MN are treating patients of hematological disorders in Japanese Red Cross Society Wakayama Medical Center. KO is a pathologist in Japanese Red Cross Society Wakayama Medical Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"In accordance with the Declaration of Helsinki, patient samples were obtained after written, informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"320"}}